NCT02605707View on ClinicalTrials.gov

Autologous Endothelial Progenitor Cells Transplantation for Chronic Ischemic Stroke

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

February 29, 2020

Conditions
Stroke
Interventions
DRUG

Intravenous stem cell transplantation

Intravenous injection of autologous endothelial progenitor cells transplantation

Trial Locations (1)

510282

Zhujiang Hospital, Southern Medical University, Guangzhou

All Listed Sponsors
collaborator

Second Affiliated Hospital of Guangzhou Medical University

OTHER

lead

Southern Medical University, China

OTHER

NCT02605707 - Autologous Endothelial Progenitor Cells Transplantation for Chronic Ischemic Stroke | Biotech Hunter | Biotech Hunter